DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)

[(2S)-3-hydroxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropyl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

CIGBUIJNIAKRIV-QAYFXLHOSA-N CHEBI:170899 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: CIGBUIJNIAKRIV-QAYFXLHOSA-N
InChI Key: CIGBUIJNIAKRIV-QAYFXLHOSA-N
IUPAC name: [(2S)-3-hydroxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropyl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
Preferred name: DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
INN name: —
Synonym: —
ChEBI: CHEBI:170899

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Metabolic Dynamics of In Vitro CD8+ T Cell Activation.

Observed in differential profiles

G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h